Apeloa Pharmaceutical Co Ltd (000739) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥366.84 Million ≈ $53.68 Million USD) by net assets (CN¥6.49 Billion ≈ $950.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Apeloa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Apeloa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000739 liabilities breakdown for a breakdown of total debt and financial obligations.

Apeloa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ningbo Huaxiang Electronic Co Ltd
SHE:002048
0.039x
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
N/A
CCC Intelligent Solutions Holdings Inc.
NASDAQ:CCC
0.067x
Solar Applied Materials Technology
TWO:1785
0.003x
Cellebrite DI
NASDAQ:CLBT
0.170x
China World Trade Center Co Ltd
SHG:600007
0.059x
Shurgard Self Storage SA
BR:SHUR
0.019x
Adecco Group AG Class N
SW:ADEN
0.141x

Annual Cash Flow Conversion Efficiency for Apeloa Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Apeloa Pharmaceutical Co Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.75 Billion
≈ $987.72 Million
CN¥1.21 Billion
≈ $176.88 Million
0.179x +8.18%
2023-12-31 CN¥6.23 Billion
≈ $911.71 Million
CN¥1.03 Billion
≈ $150.92 Million
0.166x -31.10%
2022-12-31 CN¥5.52 Billion
≈ $807.64 Million
CN¥1.33 Billion
≈ $194.05 Million
0.240x +98.74%
2021-12-31 CN¥5.06 Billion
≈ $740.44 Million
CN¥611.75 Million
≈ $89.52 Million
0.121x -49.90%
2020-12-31 CN¥4.39 Billion
≈ $642.49 Million
CN¥1.06 Billion
≈ $155.04 Million
0.241x -33.15%
2019-12-31 CN¥3.77 Billion
≈ $551.37 Million
CN¥1.36 Billion
≈ $199.02 Million
0.361x +44.97%
2018-12-31 CN¥3.34 Billion
≈ $489.37 Million
CN¥832.69 Million
≈ $121.85 Million
0.249x +261.97%
2017-12-31 CN¥3.05 Billion
≈ $446.31 Million
CN¥209.80 Million
≈ $30.70 Million
0.069x -0.24%
2016-12-31 CN¥2.62 Billion
≈ $382.88 Million
CN¥180.42 Million
≈ $26.40 Million
0.069x -62.22%
2015-12-31 CN¥2.42 Billion
≈ $353.65 Million
CN¥441.16 Million
≈ $64.56 Million
0.183x -46.49%
2014-12-31 CN¥2.31 Billion
≈ $337.43 Million
CN¥786.64 Million
≈ $115.11 Million
0.341x +232.78%
2013-12-31 CN¥1.86 Billion
≈ $271.86 Million
CN¥190.45 Million
≈ $27.87 Million
0.103x -58.33%
2012-12-31 CN¥1.37 Billion
≈ $199.83 Million
CN¥335.90 Million
≈ $49.15 Million
0.246x +9.18%
2011-12-31 CN¥806.67 Million
≈ $118.04 Million
CN¥181.74 Million
≈ $26.59 Million
0.225x +50.49%
2010-12-31 CN¥808.57 Million
≈ $118.32 Million
CN¥121.05 Million
≈ $17.71 Million
0.150x -42.88%
2009-12-31 CN¥794.78 Million
≈ $116.30 Million
CN¥208.30 Million
≈ $30.48 Million
0.262x +112.87%
2008-12-31 CN¥768.11 Million
≈ $112.40 Million
CN¥94.57 Million
≈ $13.84 Million
0.123x -46.98%
2007-12-31 CN¥750.11 Million
≈ $109.76 Million
CN¥174.20 Million
≈ $25.49 Million
0.232x -33.61%
2006-12-31 CN¥455.77 Million
≈ $66.69 Million
CN¥159.43 Million
≈ $23.33 Million
0.350x +64.87%
2005-12-31 CN¥411.93 Million
≈ $60.28 Million
CN¥87.40 Million
≈ $12.79 Million
0.212x +65.59%
2004-12-31 CN¥371.08 Million
≈ $54.30 Million
CN¥47.54 Million
≈ $6.96 Million
0.128x -60.01%
2003-12-31 CN¥328.83 Million
≈ $48.12 Million
CN¥105.36 Million
≈ $15.42 Million
0.320x +3160.50%
2002-12-31 CN¥286.40 Million
≈ $41.91 Million
CN¥2.81 Million
≈ $411.85K
0.010x +547.91%
2001-12-31 CN¥259.70 Million
≈ $38.00 Million
CN¥-569.79K
≈ $-83.38K
-0.002x -109.77%
2000-12-31 CN¥315.13 Million
≈ $46.11 Million
CN¥7.08 Million
≈ $1.04 Million
0.022x +133.71%
1999-12-31 CN¥307.93 Million
≈ $45.06 Million
CN¥-20.52 Million
≈ $-3.00 Million
-0.067x -154.92%
1998-12-31 CN¥248.02 Million
≈ $36.29 Million
CN¥30.10 Million
≈ $4.40 Million
0.121x --

About Apeloa Pharmaceutical Co Ltd

SHE:000739 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.10 Billion
CN¥21.16 Billion CNY
Market Cap Rank
#4834 Global
#903 in China
Share Price
CN¥18.27
Change (1 day)
-1.08%
52-Week Range
CN¥13.64 - CN¥19.36
All Time High
CN¥39.53
About

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates serie… Read more